Health-2007 1-1: Novel targets for drugs against Gram negative bacteria




Yüklə 4.62 Kb.
tarix09.03.2016
ölçüsü4.62 Kb.
(ID 1189) ConjuGate is an Israeli SME, which is interested in the following topics:

HEALTH-2007-2.3.1-1: Novel targets for drugs against Gram negative bacteria.

HEALTH-2007-2.4.1-7: Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy

Description of research Activity:
ConjuGate is developing a new Antifungal therapy for systemic treatment, which will be used for the treatment of acute invasive fungal infections in patients with compromised immune systems.
The unique technology enables to change the properties of existing drugs, rendering them safer and more cost-effective, by connecting the drug to a natural polymeric vehicle (a "conjugate").
ConjuGate's unique proprietary technology  preserving of the drug's efficacy while dramatically reducing its toxicity

Keywords: Polymer vehicle , small molecule, conjugate,antifungal, antibiotics, anticancer drugs
Description: A unique technology that enables to change the properties of existing drugs, rendering them safer and more cost-effective, by connecting the drug to a natural polymeric vehicle (a "conjugate").
Commitment: Research,Technology

Term commitment: Medium (1 to 3 years)
Expected results: New developed drugs based on our technology for the above mentioned topics.

Contact Details:

Mrs Hagit Sepkuty Beckenstein



Email: HAGIT@CONJUGATE.CO.IL
Tel: 972-8-9420760

Fax: 972-8-9420760


Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©azrefs.org 2016
rəhbərliyinə müraciət

    Ana səhifə